Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Correction to: J Exp Clin Cancer Res 41, 83 (2022) https://doi.org/10.1186/s13046-022-02295-4 Following publication of the original article [1], the authors identified minor errors in Figs. 3 and 5; specifically: * Fig. 3e: in the upper panel, the standard deviation lines and statistically lines originally overlapped; this has been corrected * Fig. 5n: the western blot for FOXM1 originally contained an erroneous ‘16h’ notation on the band; this has been removed The corrected figures are given here. [RAW_REF_TEXT] Correction [/RAW_REF_TEXT] [RAW_REF_TEXT] Open Access [/RAW_REF_TEXT] [RAW_REF_TEXT] Published:11 April 2022 [/RAW_REF_TEXT] Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation [RAW_REF_TEXT] Maria Serena Roca1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Tania Moccia1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Federica Iannelli1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Cristina Testa1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Carlo Vitagliano1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Michele Minopoli2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Rosa Camerlingo3, [/RAW_REF_TEXT] [RAW_REF_TEXT] Giulia De Riso4, [/RAW_REF_TEXT] [RAW_REF_TEXT] Rossella De Cecio5, [/RAW_REF_TEXT] [RAW_REF_TEXT] Francesca Bruzzese6, [/RAW_REF_TEXT] [RAW_REF_TEXT] Mariarosaria Conte7, [/RAW_REF_TEXT] [RAW_REF_TEXT] Lucia Altucci7,8, [/RAW_REF_TEXT] [RAW_REF_TEXT] Elena Di Gennaro1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Antonio Avallone9, [/RAW_REF_TEXT] [RAW_REF_TEXT] Alessandra Leone1 na1 & [/RAW_REF_TEXT] [RAW_REF_TEXT] Alfredo Budillon ORCID: orcid.org/0000-0002-6330-60531 na1 [/RAW_REF_TEXT] Journal of Experimental & Clinical Cancer Research volume 41, Article number: 138 (2022) Cite this article [RAW_REF_TEXT] 95 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] The Original Article was published on 03 March 2022 Correction to: J Exp Clin Cancer Res 41, 83 (2022) https://doi.org/10.1186/s13046-022-02295-4 Following publication of the original article [1], the authors identified minor errors in Figs. 3 and 5; specifically: [RAW_REF_TEXT] Fig. 3e: in the upper panel, the standard deviation lines and statistically lines originally overlapped; this has been corrected [/RAW_REF_TEXT] [RAW_REF_TEXT] Fig. 5n: the western blot for FOXM1 originally contained an erroneous ‘16h’ notation on the band; this has been removed [/RAW_REF_TEXT] The corrected figures are given here. L CAT, GPX2, SOD2, RAD51, XRCC1, BIRC5 and S